Page last updated: 2024-12-06

2-phenylthiazolidine-4-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-phenylthiazolidine-4-carboxylic acid: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID39237
CHEMBL ID4578941
SCHEMBL ID2029800
MeSH IDM0081981

Synonyms (38)

Synonym
STK723023
EN300-24455
CHEMDIV3_010937
SDCCGMLS-0064685.P001
CBDIVE_001897
4-thiazolidinecarboxylic acid, 2-phenyl-
nsc522094
nsc-522094
2-phenyl-4-thiazolidinecarboxylic acid
4-thiazolidinecarboxylic acid 2-phenyl-
42607-21-6
4-carboxy-2-phenylthiazolidine
IDI1_028495
nsc 522094
2-phenyl-4-thiazolidine-4-carboxylic acid
2-phenylthiazolidine-4-carboxylic acid
AKOS000201174
BRD-A85402630-001-01-9
2-phenyl-1,3-thiazolidine-4-carboxylic acid
HMS1504B03
2-phenyl-thiazolidine-4-carboxylic acid
2-phenyl-1,3-thiazolane-4-carboxylic acid
CCG-139353
FT-0676633
6P-115
BBL028315
AKOS016051145
SCHEMBL2029800
38984-58-6
2-phenyl-1,3-thiazolidine-4-carboxylic acid #
J-510277
mfcd00170683
2-phenylthiazolidine-4-carboxylicacid
2-phenyl-1,3-thiazolane-4-carboxylicacid
CHEMBL4578941
CS-0215407
DTXSID701284363
Z197509452
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1640018Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
AID1640019Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.82 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]